1. Home
  2. FBDT vs CRVO Comparison

FBDT vs CRVO Comparison

Compare FBDT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBDT

First Breach Inc. Common Stock

N/A

Current Price

$0.88

Market Cap

32.2M

Sector

Industrials

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

N/A

Current Price

$3.24

Market Cap

25.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBDT
CRVO
Founded
2018
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2M
25.9M
IPO Year
2026
2011

Fundamental Metrics

Financial Performance
Metric
FBDT
CRVO
Price
$0.88
$3.24
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $15.40
AVG Volume (30 Days)
★ 4.4M
207.2K
Earning Date
11-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$525.01
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.61
$2.13
52 Week High
$1.25
$10.00

Technical Indicators

Market Signals
Indicator
FBDT
CRVO
Relative Strength Index (RSI) 49.27 66.19
Support Level $0.86 $2.44
Resistance Level $0.88 $3.86
Average True Range (ATR) 0.13 0.19
MACD -0.02 0.07
Stochastic Oscillator 6.35 79.41

Price Performance

Historical Comparison
FBDT
CRVO

About FBDT First Breach Inc. Common Stock

First Breach Inc is an American defense technologies company focused on manufacturing match-grade ammunition components, finished ammunition, and developing unmanned aerial systems for commercial, law enforcement, and military markets. Its ammunition operations include the in-house production of brass cups, casings, projectiles, lead cores, lead wire, and completed ammunition. The company is also developing U.S.-made unmanned aerial systems incorporating robotics, intelligence, surveillance and reconnaissance (ISR), sensor, and precision manufacturing technologies for defense, homeland security, law enforcement, and commercial applications.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: